Clinical Trials Logo

Clinical Trial Summary

This pilot study will make a preliminary determination of the safety of ustekinumab in patients with Primary Sjogren's Syndrome (PSS) and assess the response of systemic measures of inflammation (biomarkers).


Clinical Trial Description

This is a single-center, open label, pilot trial of ustekinumab in patients with Primary Sjögren's Syndrome (PSS). Up to 15 subjects will receive an infusion loading dose of 6 mg/kg of ustekinumab at baseline, and 90 mg of ustekinumab subcutaneously at week 4, week 12 and week 20. Subjects will be followed for 24 weeks. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04093531
Study type Interventional
Source University of Rochester
Contact
Status Completed
Phase Phase 1
Start date January 15, 2020
Completion date May 11, 2022

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06440525 - A Phase 2 Study of RSLV-132 in Females With Primary Sjögren's Syndrome Phase 2
Not yet recruiting NCT03140111 - LAMELLEYE for the Treatment of Dry Eye Symptoms in pSS Patients N/A
Not yet recruiting NCT06049368 - 68Ga-P16-093 PET/CT Imaging in the Salivary Gland Phase 1/Phase 2
Not yet recruiting NCT03614299 - Eye Dryness Evaluation in Primary Sjögren's Syndrome
Not yet recruiting NCT03126383 - Inflammatory Myopathies in Primary Sjögren's Syndrome N/A
Recruiting NCT04830644 - A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome. Phase 2
Not yet recruiting NCT03765593 - Biomarkers in Primary Sjögren's Syndrome
Completed NCT01081184 - Neurotrophins Implications in Primary Sjögren Syndrome N/A
Completed NCT05670535 - Sjögren and Gynecologic Considerations
Completed NCT03226444 - Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome Phase 1/Phase 2
Completed NCT04816370 - Effects of Primary Sjögren's Syndrome on Female Genitalia and Sexual Functions N/A
Completed NCT05380804 - Cutaneous Silent Period Assessment in Primary Sjögren's Syndrome
Terminated NCT04700280 - A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Primary Sjögren's Syndrome (pSS) Phase 2
Completed NCT03130062 - Resistance Exercise in Woman With Primary Sjörgen Syndrome. N/A
Recruiting NCT03509064 - Medico-economic and Quality of Life Impact of Sjogren-associated Small Fiber Neuropathy
Completed NCT04224454 - Vaccine Coverage and Primary Sjögren'Syndrome
Completed NCT04960605 - Prognosis of Dental Implants in Patients With Primary Sjögren's Syndrome N/A
Recruiting NCT06361745 - Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases N/A